Today

Agents

Chat

Arena

Discover

More

App

F5 Q3 Adjusted EPS USD 4.73 Vs. IBES Estimate USD 4 - FFIV News | Rallies

F5 Q3 Adjusted EPS USD 4.73 Vs. IBES Estimate USD 4

FFIV•2026-07-27

Fourth-quarter outlook

Outlook Q4 revenue USD 870-890 million vs. IBES estimate USD 856.9 million
Outlook Q4 adjusted EPS USD 4.14-4.26

Q3 results and revenue

Jul 27 (Reuters) - F5 Q3 EPS USD 3.62.

Q3 revenue USD 865 million vs. IBES estimate USD 832.5 million

Related News

Oriental Culture Holding sells China International Assets Equity of Artworks Exchange to Spring Harvest for HK$ 1 million

OCG•2026-07-27

Arcus Biosciences grants new hires stock options for 12,600 shares at $29.73 each

RCUS•2026-07-27

Telesat says it is ready to execute FCC Upper C-band transition plan

TSAT•2026-07-27

Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $606,525

CYTK•2026-07-27

Stifel Financial director Maryam S. Brown sells 4,700 shares for $372,185.5

SF•2026-07-27